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Next generation sequencing (NGS) technologies, primarily based on massively parallel
sequencing, have touched and radically changed almost all aspects of research world-
wide. These technologies have allowed for the rapid analysis, to date, of the genomes of
more than 2,000 different species. In humans, NGS has arguably had the largest impact.
Over 100,000 genomes of individual humans (based on various estimates) have been
sequenced allowing for deep insights into what makes individuals and families unique
and what causes disease in each of us. Despite all of this progress, the current state of
the art in sequence technology is far from generating a “perfect genome” sequence and
much remains to be understood in the biology of human and other organisms’ genomes.
In the article that follows, we outline why the “perfect genome” in humans is important,
what is lacking from current human whole genome sequences, and a potential strategy
for achieving the “perfect genome” in a cost effective manner.
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INTRODUCTION
Next generation sequencing (NGS) technologies, primarily based
on massively parallel sequencing (MPS; Drmanac and Crkven-
jakov, 1990; Shendure et al., 2005; Bentley et al., 2008; Drmanac
et al., 2010), have touched and radically changed almost all
aspects of research worldwide. These technologies have allowed
for the rapid analysis, to date, of the genomes of more than
2,000 different species (http://www.genomesonline.org/statistics).
In humans, NGS has arguably had the largest impact. Over
100,000 genomes of individual humans (based on various esti-
mates) have been sequenced allowing for deep insights into what
makes individuals and families unique and what causes disease in
each of us (Rios et al., 2010; Roach et al., 2010; Kong et al., 2012;
MacArthur et al., 2012;Michaelson et al., 2012; O’Roak et al., 2012;
Sanders et al., 2012; Tennessen et al., 2012; Veltman and Brunner,
2012; Epi et al., 2013; Schaaf et al., 2013; Yang et al., 2013; Al Turki
et al., 2014; Fromer et al., 2014; Gilissen et al., 2014; Lawrence et al.,
2014; Purcell et al., 2014).
Massively parallel sequencing technologies continue to advance
in efﬁciency with recent improvements allowing “single pixel per
spot” imaging on patterned DNA arrays to generate many ter-
abases of read data per sequencing run (Peters et al., 2012) and the
recent introduction of Illumina’s HiSeq X, also using patterned
arrays, producing over 500 Gb per day. By our estimates, a fur-
ther several-fold increase in MPS efﬁciency will be achieved in
the next few years, including a reduction in the cost to approxi-
mately $1/Gb of raw reads. Despite all of this progress, the current
state of the art in sequence technology is far from perfect and
much remains to be understood in the biology of human and
other organisms’ genomes. Further, before large-scale adoption of
whole genome sequencing (WGS) in humans as a standard of clin-
ical practice can be realized, the quality along multiple different
metrics must improve several fold to several orders of magnitude.
These improvements can potentially lead to practically complete
and errorless reading of individual human genomes. In the arti-
cle that follows, we outline why this “perfect” WGS (“perfect
genome”) in humans is important, what is lacking from cur-
rent human whole genome sequences, and a potential strategy
for achieving the “perfect genome” in a cost-effective manner.
THE BENEFITS OF BEING PERFECT
Within the approximately three billionDNA letters inherited from
each parent and the sixteen thousand maternally inherited mito-
chondrial letters (about 6 billion total) exists a program for the
development and adaptive functioning of all of our tissues. As
such, it is reasonable to believe that perfect analysis of the human
genome will become the ultimate genetic test (Green et al., 2011;
Drmanac, 2012) for the discovery of all medically and otherwise
relevant variants. Moreover, DNA sequencing of the inherited
genome can be administered once and utilized for the entire life
of an individual. At the level of a single individual cell there can be
many changes in the genome, but averaged over millions of cells
in multiple tissues, and excluding special circumstances such as
mosaicism or other events that can cause a few dominant clonal
genomes, there is little change in a person’s genome over a life time.
There are important exceptions to this, such as the detection of
somatic mutations causing diseases such as cancer where periodic
genome sequencing would need to be done on tissue biopsies or
blood samples. Coupling perfect WGS with a complete database
of genomic variants and gene networks and their corresponding
phenotypes will allow for a powerful human health prediction
and disease prevention tool. The importance of perfect WGS is
analogous to the obvious beneﬁts of errorless readingof computer-
stored human-generated information. Error-prone retrieval of
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data ﬁles would have greatly limited the value of information
technologies and signiﬁcantly impacted their wide use in every
day life. Because nuclear and mitochondrial genomes comprise
the complete genetic information, perfect sequencing of millions
of human genomes per year will form a new irreplaceable infras-
tructure (similar to the Internet infrastructure) for growing many
industries (health, pharmaceuticals, food, sports, and education)
with the ultimate goals of improving and extending human life.
WHAT IS PERFECT?
Perfect WGS or the “perfect genome” is free of errors, meaning
there is no need to validate medically relevant variants using some
orthogonal sequencing method. DNA bases are not skipped nor
are additional bases added in a perfectly read genome and we
can be conﬁdent that everything that could affect the health of
the individual, including all de novo mutations, has been found.
In perfect WGS, all deletions, duplications, and disease-causing
repeat expansions are detected and the length of each of the 92
telomeres and 24 centromeres is accurately measured. Perfect
WGS requires the separate assembly of each parental chromo-
some (i.e., full haplotype phasing) allowing for the context of all
genomic variations to be understood. Contextual interpretation
of the inﬂuence of genomic variants upon each other is critical for
complete understanding of disease predisposition. Even a low false
positive or negative error rate would impede any extensive contex-
tual interpretation of genomic variants. Furthermore, a perfectly
read genome allows for the full understanding of the complex
interactions of genetic and environmental factors. Finally, perfect
WGSmust be cost effective, ideally less than 1,000 US dollars, oth-
erwise it will be too expensive to be broadly utilized. In practice,
it may be difﬁcult to ever achieve a truly “perfect genome,” but a
genomewith a few errors and some unresolved repeat sequences is
very obtainable and for the purposes of improving human health,
it is exactly what is required. This practically “perfect genome” is
what we refer to in the remainder of this article.
FAR FROM PERFECT
WHAT’S MISSING?
Over half of the humangenome is composedof repetitive sequence
elements (de Koning et al., 2011). The most popular and cost-
effective sequencing technologies are currently limited to read
lengths less than a few 100 base pairs and mate-pair distances
typically less than several kilobases; those technologies with longer
read lengths are currently prohibitively expensive forwhole human
genome sequencing or still have error rates too high for routine
use. These read architectures allow for sequencing through many
repeats, but some repetitive regions are still too long and thus
unmappable. Approximately 5–10% of the human genome falls
into these regions that are too long to be analyzed by current
technologies. Additionally, some copy number variants (CNVs),
especially extra copies of genomic regions <100 kb in length and
genes with multiple functional or nonfunctional (e.g., pseudo-
genes) copies can be difﬁcult to analyze accurately. To further
complicatematters, current sequencing technologies struggle with
regions of extreme AT or GC base content, some of which are
important coding and regulatory sequences. Finally, many rare
variants, such as de novo mutations, long insertions or deletions,
and variants having low read coverage due to various biases are
not detected due to the preference to call reference bases or known
variants in a reference-based genome assembly.
HUMANS ARE DIPLOID
Most individuals have more than 2 million locations in their
genome where the 22 autosomal chromosomes inherited from
each parent differ (Levy et al., 2007; Bentley et al., 2008;Wang et al.,
2008; Wheeler et al., 2008; Ahn et al., 2009; Drmanac et al., 2010;
Peters et al., 2012). These variants can have profound effects on the
biology of the individual depending on if they are found on the
same chromosome or opposite homologous chromosomes. Read
lengths of a few hundred base pairs or less are insufﬁcient to deter-
mine which combination of variants exists on a single parental
chromosome. As a result most whole genome assemblies are hap-
loid consensus in nature with both variants listed at each genomic
position where a difference is found, but little to no informa-
tion about the parental chromosome from which they came. For
example, in the case where two detrimental variants are found in
a single gene it is imperative to know if at least one of the parental
genes is functional for genetic diagnosis. For imprinted genes a
single detrimental variant can be disease-causing depending on
the parental chromosome on which it resides (Schaaf et al., 2013).
FINDING A SIGNAL IN THE NOISE
Next generation sequencing has begun to become more prevalent
in the clinical setting, but false positive error rates are still too
high [one false positive error in every 1 million bases (Roach et al.,
2010)] forWGS to become routine clinical practice. False positive
errors cloud the already difﬁcult analysis of WGS data, creating
potentiallymisleading detrimental variants that require additional
analysis work or sequence validation to conﬁrm. Many of these
errors come from mismapping sequence reads between genomic
regions evolved by duplication or repeat multiplication. Of equal
importance are those variants that are missed in regions that are
otherwise called or variants removed by ﬁlters during the genome
assembly process to reduce false positive errors. All clinical tests
suffer from these false positive and negative errors, however,WGS
has much room to improve on these dimensions.
LESS IS MORE
Thousands of cells are not always available in a clinical setting, but
that is the amount of DNA required by most WGS technologies.
Ideally WGS could be performed on 10 cells or less. This would
allow for the application of WGS to in vitro fertilized embryo
biopsies (Peters et al., under review Genome Research), circulating
tumor cells, circulating or other fetal cells (Bolnick et al., 2014),
and other biological sampleswith a small number of cells available.
Starting with a small amount of DNA (66 pg in 10 human cells)
requires DNA ampliﬁcation that introduces false positive errors
and other artifacts and biases making perfect WGS from a few
cells especially challenging.
TOWARD PERFECTION
Our “perfect genome” solution employs advanced massively par-
allel DNA sequencing of “co-barcoded” reads from long genomic
DNA molecules, and efﬁcient de novo assembly empowered by
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FIGURE 1 |The concept of read co-barcoding for advanced whole
genome sequencing (WGS). All four critical requirements are depicted.
(1) A genomic library is prepared from long DNA (e.g., 30–300 kb)
representing 10 or more cells. Multiple staggered long DNA fragments for
each genomic region are generated as a result of random fragmenting
during cell lysis (three fragments depicted under each parental
chromosome). In the co-barcoded read libraries these redundant long
fragments allow variant phasing, a more accurate assembly of the
genome, and ultimately de novo assembly. In this example a pair of long
proximate repeat elements, longer than the read and mate-pair length, is
shown by the large gray boxes. A and C denote single base differences
between copies of these repeat elements. Long, overlapping, staggered
genomic fragments allow for the proper placement of these repeats in
the ﬁnal assembly by exclusive linking of repeat members to surrounding
unique sequences provided by the long DNA fragments that start or end
between repeats. (2) Sequence reads generated from each long fragment
(i.e., subfragments used to produce these reads) are tagged (small
colored curved lines) with the same barcode (co-barcoded). There are
many (usually 10s–100s) of reads per long DNA fragment, most if not all
having the same barcode. Reads belonging to related (i.e., overlapped)
long fragments mostly have different barcodes. Consequently maternal
(red) and paternal (blue) fragments for a genomic region have different
barcodes as indicated by the distinct barcode numbers (253, 112, and X
for mom, 27, 367, and Y for dad). After MPS, barcodes are used to
aggregate reads from the original long fragment. Such read aggregation,
even without sequence assembly per long fragment, provides information
for variant phasing and repeat resolving when reads from overlapping long
fragments, representing the same chromosome, are used together in the
assembly process. (3) Sequence reads must cover >30% and preferably
the majority of bases in each long fragment. Consecutive continuous
reads (depicted here) or overlapping mate-pair reads (two shorter reads
from the ends of the same subfragment) can provide the needed
coverage. Sequencing the majority of bases of each fragment with
co-barcoded reads links alleles in haplotypes as, on average, 10 or more
heterozygous sites occur per long DNA fragment. (4) The read or
mate-pair length is longer than the frequent dispersed repeats (e.g., Alu,
depicted by the small gray boxes) and are correctly assembled primarily
using read level data.
these barcoded reads. The critical requirements of this fundamen-
tal and comprehensive solution for sequencing complex diploid
genomes are depicted in Figure 1.
First, a sample providing sufﬁcient (e.g., >10X) genome cov-
erage in long (e.g., 30–300 kb) DNA fragments is needed. This
redundancy allows the differentiation of true sequences from
errors and artifacts and the separation of long clustered repeats
(e.g., full length LINEs or segmental duplications) as discussed
below. Implicit in this requirement is DNA isolated from at
least several cells from one individual and the preservation of
long DNA molecules. This eliminates formalin-ﬁxed parafﬁn-
embedded (FFPE) samples, in which DNA is typically degraded,
and single cells as sources for our “perfect genome.”
Second, nearly all reads from a long fragment must share the
same unique barcode (“co-barcoding”) and that barcode must be
different from the barcodes used to tag reads from the majority of
(i.e., >80%) related long DNA fragments (e.g., overlapped DNA
fragments covering a genomic region or copies of long repeats).
However, reads from many unrelated long fragments can have the
same barcode.
Third, sufﬁcient base coverage from each long DNA fragment
(at least ∼30% and preferably >60% of bases with read coverage
per fragment between 0.5X and 2X) is needed to link most of
the sequence belonging to a long fragment and achieve almost all
the beneﬁts of very long reads (i.e., >50 kb). In the case of ideal
unbiased WGS, a total read coverage of 40X would be sufﬁcient
for 10 diploid cells with co-barcoding, although in practice over
100X would be preferred.
Fourth, a read structure, as discussed below, that allows for
the resolution of frequent short repeats (e.g., Alu and similar
repeats) and the ability to measure the length of homopolymers
and tandem repeats is important.
It is critical to satisfy all four listed requirements in this opti-
mally designed arrangement in such a manner that DNA tagging
does not add signiﬁcantly to the total cost.
DEMONSTRATION OF CO-BARCODED READS
The principles behind co-barcoded reads (Figure 1) have pre-
viously been described (Drmanac, 2006) and an experimental
implementation of these principles called long fragment read
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technology (LFR; Peters et al., 2012) has been developed. Brieﬂy,
long related DNA fragments (e.g., overlapped fragments from a
genomic region) are separated stochastically by pipetting a dilute
highmolecular weight DNA solution into physically distinct wells,
followed by multiple displacement ampliﬁcation (MDA; Dean
et al., 2002) and fragmentation to generate shorter molecules
(subfragments) suitable for short read mate-pair sequencing. Bar-
coded adapter molecules, unique to each well, are then ligated
to the subfragments. Finally, the barcoded DNA from all wells
is combined and sequenced, including reading the 10-base bar-
codes. All reactions preceding pooling are performed in the same
plate without any DNA puriﬁcation between steps enabling use
of a large number of small wells. The initial dilution and sepa-
ration of long DNA molecules is done such that approximately
10% of a haploid genome (∼300 Mb) is found in each well.
Statistically this results in a 5% chance that for a given region
of the genome overlapping molecules from each parent will be
present in the same well. When performed in a 384-well plate
there is a redundancy of ∼20 long fragments from each parent
(∼40 in total), for any position in the genome, distributed across
36 wells on average. This results in each genomic location hav-
ing DNA exclusively from one parent in 17 (2 of 36 wells have
mixed parents) wells, on average, with an overall range of 6–20
wells.
A LARGE NUMBER OF BARCODES IS CRITICAL FOR PERFECT WGS
Co-barcoding, as previously demonstrated (Peters et al., 2012),
allows for haplotyping and substantial error correction, making
it a key part of working toward the “perfect genome.” However,
384 wells do not allow for efﬁcient de novo assembly and as will
be discussed later, de novo assembly is absolutely critical for a
“perfect genome.” The problem is that with 10% of the genome
labeled by each barcode, and the repetitive nature of the human
genome, there are too many overlapping short reads from distinct
genomic regions in eachwell. The obviousway to improve this is to
increase the number of physically distinct compartments and thus
the number of barcodes, which reduces the percent of a haploid
genome for each compartment.
How many barcodes are needed? The more the better, but to
be able to measure common long repeats such as telomeres from
20 cells (∼2,000 telomeres) we would need at least 4,000 com-
partments (providing >75% isolated telomeres). This number of
compartments is also needed to accurately count mitochondrial
genomes and assess heteroplasmy as there are oftenmore than 100
mitochondria per cell. Therefore, 5,000–10,000 is a good starting
point. Using 10,000 individual compartments with 10,000 unique
barcodes and 20 cells would result in only one hundred and twenty
100 kbmolecules (∼12Mb of DNA) per barcode. This small num-
ber of bases per each barcode dramatically reduces the chance of
co-barcoding related long fragments. Additionally, 10,000 bar-
codes reduces the number of highly similar Alu repeats and LINEs
with the same barcode to <1,000 for each repeat type. However,
while 10,000 barcodes should be sufﬁcient this suggests a larger
number would be beneﬁcial for analyzing these highly redundant
DNA elements.
With more barcodes it may be more optimal to use more cells,
ideally 50 if available, to increase the number of staggered long
DNA fragments covering each genomic region. This would pro-
vide more power to separate long proximate repeats as discussed
in Figure 1. More cells would also enable more independent mea-
surements for error reduction (discussed below), assuming more
reads are generated. For 1X read coverage reading ∼60% of bases
of each long DNA molecule from 50 cells, 100X total read cover-
age is needed without any coverage bias. On average, this would
result in 30 independent reads per parental base and cost about
$300 to generate with the projected reduction of sequencing costs
to $1/Gb.
ELIMINATING LONG DNA AMPLIFICATION
Using 10,000 barcodes and 50 or more cells allows for the possi-
bility to skip ampliﬁcation of long DNA [e.g., MDA (Dean et al.,
2002), MALBAC (Zong et al., 2012), or long range PCR]. Cur-
rent long DNA ampliﬁcation strategies introduce coverage bias
and, if PCR is used (Kuleshov et al., 2014) limit fragment length
to less than 10 kb. Ultimately, this ampliﬁcation bias requires
additional read coverage, 200X or more, to assemble a complete
genome if there are no regions with severe under-ampliﬁcation.
Libraries barcoded prior to any ampliﬁcation would result in non-
overlapping adjacent co-barcoded 500–1,500 bp subfragments
generated from each long DNA molecule. Using current MPS
equipment would result in only the ends of each subfragment
being read, and thus a lower fraction of bases per long frag-
ment would be interrogated (∼30%). This would signiﬁcantly
complicate analysis and most likely would require improved read
architecture as discussed later. Otherwise, minimal long DNA
ampliﬁcation of 10–100X may provide a good balance between
the fraction of bases read per fragment and coverage bias.
HOW LONG SHOULD LONG FRAGMENTS BE?
Long DNA fragments, over 1 Mb in some cases, are needed to
phase across long genomic regions with no or a few heterozygous
loci commonly found in the genomes of non-African populations
(Peters et al., 2012) or to assess centromeric regions. However,
for resolving intermediate repeats, such as LINEs, that are longer
than mate-pair lengths random pools of one hundred approxi-
mately 100 kb fragments are more valuable than single 10 Mb
fragments (Figure 1). An optimal solution is a broad distribu-
tion of fragment lengths from 30 kb to 3 Mb prepared from at
least 50 cells, potentially using multiple different methods (e.g.,
enzymatic and mechanical) to improve the randomness of frag-
ment ends. This would provide both frequent starts of fragments
and a sufﬁcient number of very long fragments (i.e., 3 Mb). This
could be achieved by splitting cells into separate reactions prior to
lysis and then performing different amounts of DNA fragmenting
on each reaction. To preserve very long DNA, a reversible chro-
matin crosslinking process could potentially be used (deVree et al.,
2014).
CAN WE USE 10,000 BARCODES COST-EFFECTIVELY?
Five thousand to 10,000 individual DNA aliquots is achievable
with current technologies using our multi-step no-puriﬁcation
biochemical protocol (Peters et al., 2012) and there are companies
(e.g., WaferGen, Fluidigm, etc.) selling devices that can dispense
pico to nanoliters of liquid into microwells that can accommodate
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total volumes up to several hundred nanoliters. Alternatively, over
100,000 compartments can be generated easily in less than a
minute using currently available emulsion based approaches (e.g.,
Raindrop, Bio Rad, etc.) and combinatorial barcoding in nan-
odrops (Drmanac et al., 2011). As these technologies improve the
cost of using them will drop to become less than the cost of a 384-
well plate. Importantly, if nanoliter or picoliter volume aliquots
are used, the cost of reagents will be less than our current co-
barcoding process (∼$50, several microliters per aliquot; Peters
et al., 2012).
WHAT READ STRUCTURE IS BEST?
Current MPS read lengths of about 50 bases or more are suitable
for our proposed “perfect genome” strategy. However as discussed
above, long DNA ampliﬁcation will most likely be necessary if
this read architecture is used. If an approach without long DNA
ampliﬁcation proves to be beneﬁcial, a feasible near-term solution
could be improved paired-end MPS with ∼300 base reads from
each end of 500–1,500 bp subfragments (including the barcode
sequence). Cost-effective and scalable single molecule sequencing
ofmore than500baseswouldbe evenbetter if andwhen it becomes
available. These longer paired-end or single reads could improve
the resolution of repeats in close proximity to each other that
are longer than current reads but too short to be resolved by the
mate-pair read structure due to variation in the subfragment size
(generally varying from 500 to 1,500 bp). Furthermore, longer
reads reduce the negative effects of non-randomness from DNA
fragmenting. 500 base reads would also provide a more precise
measure of long triple and other tandem repeats. In our proposed
co-barcoding based strategy, longer continuous reads (e.g., 5 kb)
are less beneﬁcial, especially if they are error prone and/or more
expensive.
ERROR FREE REFERENCE FREE PHASED GENOME ASSEMBLY
Our low cost “perfect genome” solution requires 10–100 cells
and thus has to have a low read coverage per each long frag-
ment (usually less than 2X), otherwise it would be very expensive
to generate 600X read coverage (10 cells × 2 parental sets of
chromosomes × 30X standard read coverage). Therefore, the
trivial approach of collecting all reads with the same barcode
to assemble long DNA fragments is not applicable. Instead,
integrating low read coverage from 10 or more original long over-
lapped fragments with different barcodes per each genomic region
is required. We previously described an approach for variant
calling disregarding barcodes and then using barcodes for phas-
ing heterozygous variants by calculating the number of shared
compartments for alleles in the neighboring heterozygous loci
(Peters et al., 2012). Using this method we also demonstrated
that many false positive errors could be removed as it is unlikely
for errors to repeatedly occur (i.e., have supporting reads with
multiple different barcodes) exclusively on one parental chromo-
some, and if errors do occur on only one parental chromosome
they are typically from a single barcoded fragment. In both
cases, these errors can be identiﬁed and removed (Peters et al.,
2012).
The above approaches are very effective but use a reference-
biased process in the initial variant calling. Using a large number
of barcodes allows implementation of a computationally and
cost efﬁcient (less than $200 by our estimates) reference-free
or reference-unbiased assembly. Cycle sequencing used in MPS
generates reads without indel errors. This allows for the non-
gapped read-to-read alignments necessary for efﬁcient de novo
assembly especially by implementing k-mer-based read-to-read
indexing using computers with large RAM (e.g., 4TB) and 80
or more cores. Such non-gapped alignments cannot be used for
mapping reads to the reference to call indels. Read-to-read non-
gaped aligment has previously been implemented in a local de
novo assembly (Carnevali et al., 2012). Co-barcoding with 10,000
or more barcodes provides substantial localization of reads for
efﬁcient and cost-effective assembly of long de novo contigs. For
example, calling high quality heterozygous variants ﬁrst (Drmanac
et al., 2011) allows the segregation of co-barcoded reads to each
parental chromosome for each genomic region having heterozy-
gous positions. For most of the genome, this localization and
segregation allows de novo assembly of large genomic regions sep-
arately for each parental chromosome. Such advanced phased de
novo assembly would not only provide variant calling unbiased
by the reference sequence, it would almost completely prevent
calling sequencing errors ormutations introduced by DNA ampli-
ﬁcation as heterozygous variants. In this approach, the majority
of positions in a genome are called with higher accuracy as two
hemizygous calls supported by a sufﬁcient number of exclusive
parental barcodes. Phased de novo assembly using co-barcoded
reads from long staggered DNA fragments, especially from ∼50
cells, allows the resolution of variants in complex gene families
including hemizygous deletions smaller than an exon. For detec-
tion and enumeration of CNVs, counting the number of different
barcodes per genomic region separately for each parent allows for
a more precise measurement than read counts which are much
more prone to various biases. Combined with de novo assembly,
that deﬁnes CNVs by sequence junctions, this advanced LFR pro-
cess can provide a more complete and accurate genome sequence.
Developing advanced co-barcoding and efﬁcient reference unbi-
ased de novo assembly of individual human genomes is of critical
importance for the broad and efﬁcient implementationof genomic
medicine.
PUTTING IT ALL TOGETHER
In this manuscript we have outlined a proposal for achieving the
“perfect genome” sequence using current and yet to be developed
technologies. In Figure 2 we summarize our preferred end-to-
end strategy to reach this goal. Almost all parts of the process are
currently available but substantial optimization is needed, espe-
cially in making representative co-barcoded sequencing libraries
in thousands of nano-wells without long DNA ampliﬁcation and
in developing sophisticated phased de novo assembly software.
Indeed, a recently published paper by Adey et al. (2014) has shown
that co-barcoding with ∼10,000 barcodes allows for substantial
de novo assembly without long DNA ampliﬁcation. However, due
to very low read coverage per long fragment, violating one of the
four critical requirements for perfect WGS by co-barcoded reads,
a large number of cells (∼500) are required. This results in about
5–10%of a haploid genome per barcode, approximately 10Xmore
than we are proposing. Further, their method is unable to achieve
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FIGURE 2 | Integrated “perfect genome” solution. Our preferred
end-to-end proposal for achieving the perfect genome is summarized in this
table. The “perfect genome” starts with an input of 10–100 unﬁxed cells.
Cells are lysed and long DNA fragments with a broad length distribution
are released and divided into 5,000 or more compartments. Subfragments
500–1,500 bp in length are generated, without long DNA ampliﬁcation, and
labeled with a barcode speciﬁc to each compartment (co-barcoded). All
compartments are pooled into a single tube and advanced pair-end MPS
using 300 base reads is performed, including reading 10 bases or longer
barcode sequences. Reference unbiased phased de novo assembly of each
parental chromosome is performed using k-mer read indexes on large
terabyte RAM servers. Obtaining the “perfect genome” from a smaller
number of cells (e.g., 10–20) would require maximal optimization of all
steps.
substantial phasing and as such the result is still far from a“perfect
genome.”
The most important part of our proposal that is not currently
available is a high quality, affordable 300 base MPS paired-end
read length (a total of 600 bases read per subfragment). However,
given the dramatic improvement in NGS read lengths over the
past few years, we believe 300 base reads will be available soon.
As discussed, a 10–100 fold low-bias ampliﬁcation of long DNA
coupled with 100 base reads is an alternative solution if 300 base
reads are not feasible or cost-effective. It should be noted that
while we focused on human genome sequencing for this article,
the strategy outlined here is a viable solution for analyzing the
genomes of any species.
CONCLUSION
Improvements to MPS-based NGS continue to advance our abil-
ity to efﬁciently analyze a large number of individual human
genomes with high sensitivity and speciﬁcity, including separate
sequence assembly of parental chromosomes (haplotyping) with
recently reported false positive SNV errors of less than 10 per
human genome sequenced from a 10-cell sample [Peters et al.,
under review Genome Research]. Co-barcoded reads with at least
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5,000 barcodes and advanced phased sequence assembly unbiased
by the human reference genome, as proposed here, will further
improve accuracy and completeness and allow for the achievement
of the “perfect genome.” This type of low cost, high throughput
solution promises to enable the efﬁcient and accurate sequence
analysis of the entire genome of millions of people as well as from
difﬁcult to analyze samples such asmicro-biopsies of in vitro fertil-
ized embryos and fetal and tumor cells collected from the blood.
This ultimate genetic test, when applied broadly, will provide a
foundation for genomics-based precision medicine and disease
prevention through “genomic healthcare”; enabling a longer and
healthier life.
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